Evidence map›Paper›PMID 40825197›Full record

ArticleJMIR research protocols2025

Best Practice Guidance for Male Individuals Using Anabolic Androgenic Steroids in Recreational Sports Within Primary Care: Protocol for a Modified Delphi Consensus Study.

Raphael Magnolini, Oliver Senn, Stefan Neuner-Jehle, Philip Bruggmann

Abstract read
In one paragraph

Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raphael MagnoliniInstitute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-4102-9139
Oliver SennInstitute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-4422-7250
Stefan Neuner-JehleInstitute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-6260-8148
Philip BruggmannInstitute of Primary Care, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-0436-8895

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe nonmedical use of anabolic androgenic steroids (AASs) has become a considerable substance use concern worldwide, and it is a growing public health risk, particularly among male individuals in recreational sports. Individuals who use these substances for recreational purposes may experience various medical problems. However, there is a lack of high-quality guidance and consensus among medical experts regarding the adequate provision of medical care for this population.

objectiveThis study aims to develop best practice guidance for health care professionals providing medical care to individuals engaging in the nonmedical use of AASs by achieving consensus on relevant and feasible measures for the Swiss primary care context.

methodsThe Delphi consensus method will be applied in this study to develop best practice guidance, following the criteria for conducting and reporting Delphi studies (DELPHISTAR). The development of evidence-based, relevant, and feasible measures for primary care practice follows a mixed methods approach to identify the problem area by conducting 4 substudies: a scoping literature review, incorporation of medical experience, peer involvement, and the selection of a heterogeneous research steering group of medical experts based on individual and group discussions. This Delphi consensus study consists of 3 rounds of anonymous web-based surveys with medical experts in primary care (N=25 Delphi panelists). Recruitment will occur through a network of primary care experts at the University of Zurich. Participants will rate each measure for relevance and feasibility using a 5-point Likert scale and provide comments and recommendations for additional measures. Each measure will require more than 75% agreement in both relevance and feasibility to achieve consensus. Descriptive statistics will be used. Aggregated ratings will be statistically analyzed for response rates, level of agreement, medians, and IQRs. Qualitative responses will be analyzed thematically and evaluated by the steering group for inclusion in subsequent rounds. The final draft of the resulting best practice guidance will be reviewed by an external board of medical associations, and approval will be sought before publication and dissemination.

resultsThe resulting best current clinical guidance is expected to be published in the summer of 2026. Ethics approval was received from the local ethics committee for this study.

conclusionsWith the development of high-quality best practice guidance for health care professionals in primary care, this Delphi study will help close the existing treatment gap among people using AASs. As a strength, primary care offers low-threshold access to health care, chronic care management, and coordination within the health care sector for patients experiencing multiple AAS-related health complications. The Delphi technique is an appropriate study design to develop consensus among a group of medical experts, with the strength of maintaining anonymity throughout the survey process. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/65233.

Indexed as

Anabolic AgentsPractice Guidelines as TopicSportsAnabolic Androgenic SteroidsConsensus Statements as TopicDelphi TechniqueHumansMalePrimary Health CareSwitzerlandAnabolic AgentsAnabolic Androgenic Steroidsanabolic androgenic steroidsandrogenic steroidDelphi consensusdopingimage- and performance-enhancing drugsmaleprimary careprotocolquestionnaire techniquerecreational sportssteroidsstudy protocoluser

Identifiers

PMID40825197
PMCPMC12402736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.